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Abstract
Health-related stigma is increasingly becoming a major public health issue that is receiving more
attention. Young adults with sickle cell disease (SCD) are at risk for health-related stigmatization
due to the many challenges of the disease. SCD includes the lifelong challenges of managing the
chronic illness while accessing and navigating the health care system. The burdens of the disease
can affect all aspects of the lives of individuals with SCD to include physiological, psychological,
and social well-being. Although others may be involved in the process of stigmatization, the
purpose of this paper was to support the need to develop patient-oriented interventions to prevent
and treat health-related stigma in young adults with SCD, as these individuals may face health-
related stigma throughout their lives, but especially immediately after transitioning from pediatric
to adult care. Additionally, the Revised Theory of Self-Care Management for Sickle Cell Disease
is offered as a framework from which theory-based interventions can be derived.
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INTRODUCTION
Stigmatization is the process of identifying an attribute of a person or group and associating
the attribute with a stereotype that negatively labels or brands another in a way that is
perceived as disgraceful by society.1-3 More specifically, health-related stigma refers to a
form of devaluation, judgment, or social disqualification of individuals based on a health-
related condition.4 Health-related stigma is increasingly becoming a major public health
issue that is receiving more attention as stigmatization adds to the burden of individuals and
families affected by sickle cell disease (SCD). Despite this, there is minimal information in
the literature about SCD and health-related stigma. SCD refers to a family of inherited
autosomal recessive genetic disorders that affects about 1 in 365 African Americans, with
approximately 89 079 having the disease in the United States.5,6 Individuals who have sickle
cell disease produce abnormal hemoglobin S molecules. Many of the clinical manifestations
of SCD are due to deoxygentation, vaso-occlusion, and tissue necrosis. Upon deoxygenation
or extremes in temperature, the hemoglobin S molecules cause the red blood cells to assume
a sickled shape and adhere to the vascular walls as a result of polymerization. Consequently,
the sickled cells can lead to occlusion within the capillaries and small vessels, causing pain,
tissue necrosis, and eventually anemia and ischemic organ conditions.7-10 The clinical
manifestations of SCD often lead to unpredictable episodes of pain and feelings of
inadequacy regarding their care,11 which may be due to health-related stigmatization.
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Much of the literature on health-related stigma originated from infectious diseases such as
human immunodeficiency virus (HIV)/AIDS, tuberculosis, and leprosy as well as from
mental health conditions such as schizophrenia.12,13 HIV/AIDS-related stigma has had a
significant impact on the health and well-being of individuals around the world for 2
decades.14 According to Sartorius,15 “stigma evokes negative attitudes and feelings and
usually results in discrimination of the person or institution in various walks of life.” This
level of stigma can lead to unjust disadvantages for the stigmatized, including direct
discrimination on the job, in schools, and within families, and may impact the receipt of
timely and quality health care. Health-related stigma can have a deleterious affect across the
lifespan on individuals being stigmatized.
Individuals with chronic diseases such as chronic obstructive pulmonary disease and chronic
pain also face health-related stigmatization. They may feel exiled from the healthier world
and feel disgraced due to health encounters and lack of support by providers, friends, family,
the community, and the workplace.16,17 The purpose of this paper was to support the need to
develop patient-oriented interventions to prevent and treat health-related stigma in young
adults with SCD, as these individuals may face health-related stigma throughout their lives
as they live with a chronic illness, but especially as they transition from pediatric to adult
care. Additionally, a theory is offered from which interventions can be derived.
HEALTH-RELATED STIGMA DURING CHILDHOOD IN INDIVIDUALS WITH
SICKLE CELL DISEASE
Many children and adolescents with SCD are challenged by a myriad of complex
psychosocial issues, which may be triggered or exacerbated by stigmatization. The
magnitude of childhood stigma and the potential for associated psychosocial adjustment
issues in children and adolescents with SCD can be explained within the context of
psychological, social, and cultural implications.
Pinckney and Stuart18 highlighted the significance of understanding the psychosocial
implications of living with SCD and adaptation threats in children and adolescents:
Some of those psychosocial factors are interpersonal skills (eg, self-esteem,
assertive communication difficulties), stress-producing (eg, decreased coping
strategies, decreased knowledge about SCD), and family factors (eg, cohesion,
organization and control, family support, parent-child relationship problems).18
The onset of the stigmatization may begin with the mother of the affected child. In a study
of Canadian mothers of children with SCD, mothers reported that SCD stigma was
exacerbated for racial and ethnic minority groups.19 These mothers reported daily coping
challenges such as fear of their children dying; separation anxiety; and feelings of
helplessness, loneliness, and isolation. Trzepacz, Vannatta, Gerhardt, Ramey, and Noll
found that relative to the primary caregivers of their peers, primary caregivers of children
with SCD perceived their children as having more total problems, particularly emotional
problems, and less total competence.20 These daily challenges and perceptions of mothers of
children with SCD may lead to heightened levels of overprotective behaviors. During life
review interviews with middle-aged and older adults with SCD, participants identified 2
primary factors that may negatively influence self-care behaviors and overall health
outcomes: the experience of painful crises and parental behaviors, specifically behaviors
characterized as overprotective.21
Sociodemographic variables such as race, gender, age, socioeconomic status, and education
also affect psychosocial adjustment in children and adolescents with SCD.22,23 As children
grow and progress through the stages of human development, complications related to SCD
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can become even more challenging. Children and adolescents are often forced to deal with
issues related to school absenteeism, increased use of the health care system, decreased
school and social activities, as well as poor adaptation.24-28 Children with SCD can also be
affected by health-related stigma that originates from teachers as well as peers.29 Children
and adolescents may experience low self-esteem, embarrassment, and other complications as
a result of stigma. In a study conducted by Patel and Pathan, due to the stigma of SCD,
children with sickle cell trait as well as children with sickle cell anemia were concerned
about their illness and the perception of looking different compared to their peers.30 They
also expressed concern that the illness was burdensome to their families and siblings.
Adolescents may be challenged by issues related to body image such as delayed growth and
late sexual maturation as well as bone age retardation, small body mass, delayed menarche,
hypogonadism, and delayed secondary sex characteristics among adolescents with sickle cell
disease.31-33 Mainstream society may impose negative stereotypes on children and
adolescents from racial and ethnic minority groups as a result of these factors, which may
result in stigmatization.1,34 The increased use of the health care system only negatively
impacts the sickle cell disease–stigmatization cycle that continues for the young adult with
SCD.
HEALTH-RELATED STIGMATIZATION FOR YOUNG ADULTS WITH SCD
Problems that begin in childhood are continued into adulthood, creating opportunities for
young adults with SCD to be stigmatized. In 1973, life expectancy was 14 years.35 Because
persons with SCD were not expected to live into adulthood, many may have been
overprotected during childhood. Notably, older adults with SCD have frequently indicated
that they viewed their parents’ overprotective behavior as being demonstrations of caring.21
In addition, these chronically ill children suffered the effects of social deprivation as a result
of prolonged hospitalizations. Adolescents with SCD acknowledge the importance of
transition but demonstrate poor preparation for transition to adult-oriented care.36,37 They
often leave pediatric care without adequate transfer preparation, and their readiness to
transfer is not a major consideration in the decision to transfer them.38 Without adequate
preparation to seek health care as an adult patient, young adults may become stigmatized,
especially when seeking care for acute pain. The extent of treatment of a painful SCD crisis
depends on the health care provider, who assesses the SCD patient’s presentation and
ultimately decides whether the individual’s report of pain is credible and deserving of
treatment.21,39-41 In a cohort study of 940 subjects, it was found that most children with
SCD now survive the childhood years, but young adults who transition to adult medical care
are at high risk for early death, especially shortly after transition.42 As children age out of
pediatric services, they are more susceptible to changes such as loss of an established
primary medical home, access to ambulatory care, and health insurance.43 The lack of
adequate transition can lead to recurrent hospitalizations, poor trust, and worse outcomes for
this vulnerable population.44 Thus, the transition to adult care is critical for young adults to
appropriately access the health care system. Even today, persons with SCD may not develop
the skills to fully participate in taking care of their own health needs, and some are not
prepared to assume the responsibilities of adult health care seekers.
People afflicted with SCD often experience a life punctuated by unpredictable painful crises
and feel inadequate to influence the quality of their care.45 For these reasons, the majority
(80%) of adults with SCD avoid the health care system whenever possible and manage their
pain at home.46 However, for individuals with SCD who do seek acute care, the majority of
visits are related to painful crises.47,48
The credibility or trustworthiness of young African American adults with SCD is often
questioned by health care providers, who label patients as malingerers or manipulators, or
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even drug seekers.40,41,45,49,50 Indeed when individuals with SCD request specific pain
medications, clinicians often interpret this as drug-seeking behavior,51 though no scientific
evidence suggests that people with SCD will become drug dependent if their pain is treated
with narcotics.52
Age plays a role in utilization of health care services and coping with SCD. Of those
individuals with SCD seeking acute care and rehospitalizations, those aged 18 to 30 years
are the most frequent.6 Older individuals tend to use outpatient services and prayer, while
younger individuals are more likely to use the emergency department and cope by ignoring
pain and using heat and cold or massage.53, 54
Currently, adults with SCD who present in emergency departments with complaints of an
acute pain episode may wait an average of 90 minutes for the first analgesic to be given.55
The delay may be due in part to the fact that the pain of SCD is poorly understood and it is
difficult to objectively assess a pain crisis. Additional barriers to adequate pain management
include the fact that most individuals with SCD in the United States are African American,
and many are of lower socioeconomic status.56 In a study to determine whether differential
opioid prescription by race in emergency departments has diminished since 2000, it was
found that white patients were significantly more likely to receive opioid prescription than
black patients.57 Thus, when young adults with SCD seek treatment for acute pain in an
emergency department, there is great potential for racial stereotyping, mistrust, and
problematic physician-patient communication.58 These factors may result in a negative pain
management experience.
Stigmatization or stigma-related behaviors and depression have been linked in the literature.
A study of 232 adults with SCD59 found that respondents reported higher levels of
depressive symptoms (32%) than the overall US population (9.5%). Depression in
combination with episodes of poorly managed pain may lead to feelings of inadequacy and
even suicidal ideations in adults with SCD.60 Anie and Green found that adults with SCD
commonly reported low self-esteem and feelings of hopelessness as a result of frequent pain,
hospitalizations, and subsequent loss of employment.61 An adult with SCD said, “It’s
devastating for a person to be in pain but not to be believed. It makes you feel less than
human. The trust is broken when the person you come to for help reacts negatively.”62
Negative pain management experiences may result in psychological disturbances, such as
depression and anxiety, are often associated with a diminished ability to cope with pain and
further perpetuate the cycle of pain intensity with significant impact on health outcomes.63
STIGMA REDUCTION INTERVENTIONS
Strategies have been developed to reduce stigma and inequities related to health at multiple
levels. Interventions have been developed for conditions such as HIV/AIDS, leprosy,
tuberculosis, epilepsy, and mental illness.64,65 Goals in implementing stigma reduction
strategies are to prevent delays in health services, to decrease risk of transmission, and to
raise awareness and sensitivity about stigma-related issues for many people, as well as the
affected individuals. Heijnders and Van Der Meij conducted a literature review that
identified several levels for implementing stigma reduction strategies and interventions and
found that strategies aimed at individual and community levels proved to be the most
effective.64 Individual or intrapersonal strategies include treatment, counseling, cognitive-
behavioral therapy, empowerment, group counseling and self-help, advocacy, or support
groups. Community-level strategies include education, contact, advocacy, and protests.
Currently, there are no published SCD-specific theory-based interventions aimed at
preventing or treating health-related stigma.
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THEORY-BASED STIGMA INTERVENTION FOR SICKLE CELL DISEASE
In individuals with SCD, a severe SCD crisis that results in the need for hospitalization
usually evolves through 4 distinct physiologic phases: (1) prodromal; (2) the initial evolving,
infarctive phase; (3) the established phase, and (4) the resolving, healing, recovery,
postcrisis phase.66,67 During the first, the prodromal phase (pre crisis), patients develop
symptoms of numbness, aches, and paresthesia in the sites subsequently affected by pain.
Other reported signs and symptoms of the prodromal phase include fatigue, jaundice of
sclera, nausea and vomiting, change of appetite, and stiffness in joints.68 This phase can last
up to 4 days, and individuals describe the pain as a low-intensity ache. The ability of an
adult with SCD to recognize and respond to the cues of onset of an SCD crisis as well as the
transition through differing phases of the SCD crisis may make a significant difference in
patient presentation and treatment—that is, if adults with SCD present for treatment during
the 2-to 4-day period of low pain intensity, they may be able to avoid the need for
aggressive pain management and inpatient hospitalization and have their prodromal phase
pain adequately addressed.
Increased cue recognition and seeking care early during the prodromal, or precrisis, phase
would be more effective for adults with SCD in preventing the evolution of an acute pain
crisis or the necessity of an inpatient admission via the emergency department.
Unfortunately, there have been few studies about the sickle cell crisis prodrome.69,71 Murray
and May reported that 58% of 102 patients experienced a prodromal phase of an impending
painful crisis up to 24 hours before developing features typical of their usual crisis.70
Akinola and colleagues69 reported that 12 of 14 patient premonitions were followed by a
typical painful crisis that required either home treatment (n = 4) or hospitalization (n = 8). It
has been established that therapeutic interventions are more likely to be effective during the
earlier phases of a crisis.71 Ballas describes the SCD prodrome as “an intriguing entity that
needs further study.”67 Moreover, it may provide an avenue for the initiation of proactive or
anticipatory analgesia72,73 in order to abort an evolving crisis and to prevent the evolution of
painful crises.
Young adults with SCD who are admitted through emergency departments must be
intensively treated to be stabilized prior to admission.74 Emergency department visits could
be avoided if patients presented earlier to a primary care setting that provided both medical
and psychological support to interdict pain crises and prevent severe crises.75,76 The earlier
therapy is introduced, the better the clinical outcome for adults with SCD.
To increase the potential for appropriate and timely treatment, adults with SCD must be able
to communicate substantive information to the health care provider in order for the provider
to arrive at the conclusion that this is a well-informed, credible individual presenting in the
prodromal phase of a sickle cell crisis. The adult with SCD needs to know what information
the health care provider needs and how to communicate that information. Improved positive
self-presentation is important for African Americans to get the best medical care.77 The
more information the adult with SCD provides, the greater the likelihood that the provider
can devise an individualized treatment plan in collaboration with the patient while avoiding
stereotypes of adults with SCD and their consumption of opioid analgesics.78 Positive self-
presentation can be improved through communication skills and, therefore, adults with SCD
may be more likely to receive individualized, proactive pain strategies to improve the
quality of their pain management experience.77
The Revised Theory of Self-Care Management for Sickle Cell Disease, developed by the
first author (Figure 1), focuses on vulnerability factors and self-care management resources
that influence health outcomes and can be used to design a theory-based intervention for
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young adults with SCD. In the model, vulnerability factors (lack of sickle cell crisis cue
recognition/response, number of complication, number of sickle cell crises per year, and
overprotection) negatively impact health outcomes (pain management experience,
depressive symptoms, self-esteem, and perceived health-related stigma). However, self-care
management resources (self-efficacy, coping behaviors, social support, self-care ability, self-
care actions, and assertive communications skills) can positively mediate the relationship
between vulnerability factors and health outcomes. A subset of the theory can be used to
design interventions to reduce health-related stigma, a health outcome, by focusing on
specific antecedents—lack of cue recognition/response and ineffective communication skills
—which contribute to satisfaction with the pain management experience and health-related
stigmatization. An intervention that focuses on cue recognition/response and communication
skills is hypothesized to improve these outcomes by reducing the potential for health-related
stigmatization and improving the pain management experience. In vulnerability
management, the factor of focus in the intervention is lack of sickle cell crisis cue
recognition/response, the self-care management resource is assertive communication skills,
and the health outcomes are the pain management experience and perceived health-related
stigma.
SUMMARY
Health-related stigma is a challenge for young adults with SCD. The stigmatization may
begin in childhood, but it is often most evident as young adults transition from pediatric care
to adult care. Moreover, the stigmatization may hinder care seeking for the acute pain
exacerbations of pain—the hallmark of the disease. Health-related stigma can have
detrimental effects on the lives of individuals and families living with SCD. It has been
supported that improving provider communication improves the health care encounter—in
particular, trust—in individuals with SCD.79 However, there have been no published studies
examining the impact of improving the communication skills of the individual with SCD.
One way of improving communication is presenting for care before pain impacts
communication. It is important to design interventions that improve communication skills
and, thus, care seeking in individuals with SCD as a means to eliminate or reduce health-
related stigma.
Theory-based interventions to impact health-related stigma should be designed considering
the context from which the stigma emerged in order to assists individuals to overcome the
challenges of health-related stigma. The Revised Theory of Self-Care Management for
Sickle Cell Disease offers a framework to develop interventions to prevent and reduce
health-related stigma. Theory-based interventions will empower young adults with SCD
with the skills to advocate for themselves and communicate their needs in a timely and
effective manner.
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